CIK 0001638287
- Non-accelerated filer
- Smaller reporting company
MetaVia Inc.
Sign in to watch- Ticker
- MTVA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472389984
- Phone
- +1 857-702-9600
- Business address
- 545 CONCORD AVENUE, SUITE 210, CAMBRIDGE, MA, 02138
- Former names
- NeuroBo Pharmaceuticals, Inc., Gemphire Therapeutics Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 19 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-07-27 | Salsbury Michael Director | Grant or award | +12,500 | 100,000 | ||
| 2023-07-27 | STRICKLAND D GORDON Director | Grant or award | +87,500 | 87,500 | ||
| 2023-07-27 | STRICKLAND D GORDON Director | Grant or award | +12,500 | 100,000 | ||
| 2023-07-27 | GROVES JASON L Director | Grant or award | +87,500 | 87,500 | ||
| 2023-07-27 | GROVES JASON L Director | Grant or award | +12,500 | 100,000 | ||
| 2023-07-27 | Glickman Mark A Director | Grant or award | +25,000 | 25,000 | ||
| 2023-07-27 | Glickman Mark A Director | Grant or award | +12,500 | 37,500 | ||
| 2023-07-27 | Kim Na Yeon Director | Grant or award | +87,500 | 88,959 | ||
| 2023-07-27 | Kim Na Yeon Director | Grant or award | +12,500 | 101,459 | ||
| 2022-07-26 | Kim Na Yeon Director | Other acquisition | +4,671 | 4,671 | ||
| 2022-07-26 | E&Investment, Inc. 10% owner | Other disposition | −1,445,267 | 2,890,533 | ||
| 2022-07-26 | Kim Na Yeon Director | Other disposition | −1,445,267 | 2,890,533 | ||
| 2022-06-09 | Kim Na Yeon Director | Grant or award · Nonstatutory Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-06-09 | GROVES JASON L Director | Grant or award · Nonstatutory Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-06-09 | Kim Hyung Heon Director | Grant or award · Nonstatutory Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-06-09 | Kang Richard Director | Grant or award · Nonstatutory Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-06-09 | STRICKLAND D GORDON Director | Grant or award · Nonstatutory Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-06-09 | Salsbury Michael Director | Grant or award · Nonstatutory Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-06-09 | KOVEN ANDREW I Director | Grant or award · Nonstatutory Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-01-27 | STRICKLAND D GORDON Director | Grant or award · Non-qualified Stock Option (right to buy) | +40,000 | 40,000 |
Page 3 of 7 · 135 trades